{"name":"Sionna Therapeutics Inc.","slug":"sionna-therapeutics-inc","ticker":"","exchange":"","domain":"sionna.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxQbE9kSmQtYlZKNzJyV1R0MmRJc2ZZa0NWdmdLaDY5czhSdG5lc2VBNENYSkxYRzRtSE5saS05QUdBV0traWUxZmxIZEJLbldIZ0UyelFBT2JsOUdoRmdBUTVMOWkxdVRxTUN1Z1hQUGRFX2EyeGlxM0R4b3FtUzAzQzhaVWZtVnlhem1pOWtkd0FTaFR4SkVRY0VfdWN5czlpaGVIeEw2TmJ5c3RERmFRTE8yemY3LUJuN2h5cThRQWNJOWF1a2dKdXRYejB6VlNNVkVwaVA1Z2p5YllISEw3VGY4SXFmS3dEdzhSdjFwUjdMSjlWQU9qR3hzcnJ5elhNVjZORlBzdkg4eWR4Y3VOcG9xRDgxcjZ0Ul9WclFYSnJuT2hCcTlsTEhVUG9GZF9jZ1M2OG1lV1ZmRXBEZ1E?oc=5","date":"2026-01-09","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Viking Therapeutics (VKTX) and ANI Pharmaceuticals (ANIP) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Viking Therapeutics (VKTX) and ANI Pha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPUGk3MUZLWWdyZnVMSG9oaGh4MTNOelRXakxvNzFaY2M5OEt2Q0t2NUU3RUxKQ3pjOGR1NVRIQ1Fxa3FHVmlBRmlpdk5pM0tGUDJRM01CWFRXMjJDaDN4MHVRZ19vOTVCWTRNb2owdnA3TGdNM1JLaWRxams4Y0NRbDU0cTBrZjM2aDVILVkwWUgyMjZXUTZJOEcxTzkxUFZxWDExblRzU3N6T1h6SXJFQTVHbnNGeEYteVJTZGFTcFRxQ0FzTVdaU2dsNUdudnIzak9TWGczQXFnNDY4RVRDNzdZUDBHenVxWHlVazR3NW9pNkJBY0lJVi1CY1gzSjFJcTVqZjFoMG1zTzRFbWRTd2lKMGJ1WlU?oc=5","date":"2025-12-30","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Zevra Therapeutics (ZVRA) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Zevra Therapeutics (ZVRA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxONmd4cHNfcDNiSy0zWXE4LXNpa0dHRDVxTmZ6RzBrLVZpMW9qQWlORE93cFo4VEh5MS0zV1B2OXhfMGEtSE10dFcxN3k5NGtXeGpJVFp4cl94NWRGUy16OXRza1lESkJwOG56dFVxZGZxeFdySU9SX3dhVzdTckRNcUV4dVNxUQ?oc=5","date":"2025-10-06","type":"pipeline","source":"The Business Journals","summary":"Only Mass. biotech to go public this year grows headcount 71% - The Business Journals","headline":"Only Mass. biotech to go public this year grows headcount 71%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNczRCVnRTMEZHSXNtT18xU2NhZHdHdEZJWkIwdlZBaFFuQnphZ1c5S19UOU9BX2V1dk9KWGhMUHo2eUQ1d1F6aFVpT0xEb1E5eVh6Qm9tQXhhdW43empxTTdfd1VFUDNuTXdCVXhZUjJTMFlHUHgxWk5lSzVpcjFwTS11dWJnd3NBWXVZa1dWeXdMVnFTUmQ1REpnWG5rZENjX2R4bTBhUTBSTFJGOVZaaXhNNVpWN3RBeHhTeVRmdXUyYkI5R2tzSmlKZEliSXlISHJBck1lcFdJM0JySldOd0pmclVDRkZERTFXVXdub29fTGZTREU1U0hwQUZfUU9G?oc=5","date":"2025-09-15","type":"pipeline","source":"Citeline News & Insights","summary":"Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights","headline":"Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQejVOQWEzZlFvQV9sYlB3ZkpsbC1MdVk2aDBLa2gxOVF2S3RiT0dHUURIOWc3VVUzWGgyNHVOUVFfVW5WYmdiNlYtdVp0M2k3M25Rb2JldERDQTZnVGhiSUZveDlGOGRRdVB4cHhIRWNwXzRtU0YyeHlZWW5YeHB3WjBwWVhBY1pWT09oek1heGhzNnVuMHVibGl6Vy03YUk?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPO activity slows, but 2025 returns are surging - BioWorld News","headline":"Biopharma IPO activity slows, but 2025 returns are surging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNOUhxUE9QLVNDdmFLWGZud3cyVXJKWW9zQVNUalJrRzZGWTdKd3dRTXlvUkEtb29vYlhCZFczMjJ4S3MtTzVEcXZGaXZpZUFkX3pnOFFVN3luZnZfY2hZeFNsckctZFhma3pzSTU2clZwdGlBd2taWVByeHNfcmpaelg5RVJzNlUzRHMyaF9PdUxldF9vQzNkaWFScFBzdDZyZVBwcVpwSGplMnNYdmdKMzZFTQ?oc=5","date":"2025-09-08","type":"pipeline","source":"citybiz","summary":"Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer - citybiz","headline":"Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOSmFWbjVGbzBQNl9EXzJ0VjRhVDZsd1dwcWhtdUpRdUZMeW1uZF9wR1JHRHNzTHRVazFCdEZETVNodC05TE5wRnhELU0tN2p5VUdMNGdyNjc2b1B6SmVXMldscHZmdXpsWEY5RE9xYlAzQVpfSkk2RHZXMTcycnZ1OF9KOXpXWmJ0RzhWTjhtbkE3eDFYd1RWRmNmdHlBOUw5WFZzZ1RuSl8wV084WlJyNmYzN2lsUXZ0ZUlPaFM2SQ?oc=5","date":"2025-08-22","type":"pipeline","source":"seekingalpha.com","summary":"Sionna Therapeutics: A Differentiated Bet In The $12 Billion Cystic Fibrosis Market - seekingalpha.com","headline":"Sionna Therapeutics: A Differentiated Bet In The $12 Billion Cystic Fibrosis Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNekpuOV9fZVFXekZJTWlieTFqRmp0R2FkUVo5SGhWaWNDUVVCdUtnRjNxQ29QeDVHakl6UnMycUlKNF8zVkVLNHlxdTJJaTByc00wdnNVNG5iMUdVcDJHVkp0dnRBcmZwRm5uZXdXLVZMYzd2UEw1SjJKMlhWQW5ibXc2ZmlPXzBGc2Y3TFBn?oc=5","date":"2025-02-25","type":"pipeline","source":"Yahoo Finance","summary":"Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market - Yahoo Finance","headline":"Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOd011dW5UUC0ybWh1RlFPN2ZtSjBxdkZ3NFpoUHpqVWJoZ3dTZVNpQUNRYU9FTS1LZUg2Vzd5bmVJdnlNYjdIWDNOWU14cXliN0VUdXBqNWtNRHNJTjEyUkdDVXowd2ZzaVNKNXY5bVp6aUJVS1NCblVsd0NKVlJCT1l4Skh4amNLUDMycC1tbHBaZVpoSlB5b0k0RFZsV2NpbDNCRlMxNlZCVlU?oc=5","date":"2025-02-09","type":"pipeline","source":"MedCity News","summary":"Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline - MedCity News","headline":"Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPOUVHcVp6LVBnY0xqZ1N6RTdVbUxWc3dLNHBXb3dSY1VOcDRDRV8zTDFJOUF5OTdJZ0lkYXZQdlp5T2FZNkVTc3A5eUdXOFNPSGxCZUN4Y1daTHhMLUZwS2Y5THV1aWhfbzNTQWc3cVp5NjdnMWh2bkgyNFdBMU5zVW53?oc=5","date":"2025-02-06","type":"pipeline","source":"BioPharma Dive","summary":"Vertex challenger Sionna prices $191M IPO - BioPharma Dive","headline":"Vertex challenger Sionna prices $191M IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNS1pKWVZ6U2diMk1RR0xOSFYzY2haTmMzZVloUG4xdlpLZjZodGVMQVR4azJpazVvd0tlY1Fxbk5DRXhxTkloWEozMXJ4bmo1aUdmR0lXbVhsOUdzV1NueUpETDlZcHdfa3hhcU1ZVnFQbUVJNXJrUF9hNU1QSEs0cVZmcXRPRndiRjVCSU00SQ?oc=5","date":"2025-02-03","type":"trial","source":"Fierce Biotech","summary":"Sionna eyes up $156M IPO to fund cystic fibrosis trials - Fierce Biotech","headline":"Sionna eyes up $156M IPO to fund cystic fibrosis trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOTlZiMWxBWXJ2TXFtRGFpUHFKbkJmeDBVa0s2UUFBZ3I5SjM5RUN6dWhUbmdFTVdvTFJId2FLTUdaMlN6VnJ2TnBJMWlRTTUwRTRXYjB3YnBGY3J3SVYxWldfelRCMWZISWs1R1hGVEVsVGhpVGZhdHBZcXJfVGRDcjlxX0wtYXNMT0RZVE1ES0cxMnRibWYw?oc=5","date":"2024-07-16","type":"pipeline","source":"BioPharma Dive","summary":"Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex - BioPharma Dive","headline":"Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}